MedTrace Logo

Quantitative US for Hepatic Steatosis

NCT04180631 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 124

Last updated 2021-08-19

No results posted yet for this study

Summary

The purpose of this study is to investigate the diagnostic performance of quantitative ultrasound imaging parameter for the assessment of hepatic steatosis in patients with non-alcoholic fatty liver disease using magnetic resonance imaging proton density fat fraction (MRI-PDFF) and MR spectroscopy as the reference standard.

Conditions

  • Hepatic Steatosis

Interventions

DIAGNOSTIC_TEST

Quantitative ultrasound imaging parameter (QUS)

Quantitative ultrasound imaging parameters (QUS) are analyzed to evaluate hepatic steatosis

Sponsors & Collaborators

  • Samsung Medison

    collaborator INDUSTRY

  • Seoul National University Hospital

    lead OTHER

Principal Investigators

  • Jeon Min Lee · Seoul National University Hospital

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-03-05
Primary Completion
2020-01-19
Completion
2020-01-19

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04180631 on ClinicalTrials.gov